Report Descriptions:

The Global Companion Animal Diagnostics Market was estimated at USD 6.95 billion in 2026 and is projected to reach USD 18.1 billion by 2035, reflecting a robust CAGR of 10.05% over the forecast period from 2026 to 2035. The Companion Animal Diagnostics market report offers a comprehensive and nuanced view of the industry, moving beyond conventional analysis. It provides a thorough examination of the markets dynamics, encompassing a detailed exploration of the factors propelling growth, such as evolving economic conditions, advancements in technology, shifts in regulatory policies, and changes in consumer behavior. Furthermore, the report discusses the projected Compound Annual Growth Rate (CAGR), providing stakeholders with a clear understanding of the market's expected growth trajectory and offering data-driven insights into future market dynamics.

The Companion Animal Diagnostics market under analysis is characterized by dynamic growth and evolving trends that are reshaping the competitive landscape. With 2025 serving as the base year for this Companion Animal Diagnostics market study, recent data highlights a significant expansion driven by technological advancements, rising consumer demand, and a growing focus on innovation. Companies are refining their go-to-market (GTM) strategies to effectively capture these emerging opportunities and respond to the rapidly changing market dynamics.

Key trends influencing the Companion Animal Diagnostics market include the rapid adoption of digital technologies, the integration of sustainable practices, and the increasing importance of customer experience. These trends are not only driving growth but also creating new challenges for industry participants, who must adapt their GTM strategies to navigate regulatory changes, supply chain disruptions, and fluctuating economic conditions. Despite these challenges, the Companion Animal Diagnostics market is poised for sustained growth, with emerging markets playing a critical role in the expansion of the industry.

Looking ahead, the Companion Animal Diagnostics market is forecasted to continue its upward momentum through 2035, supported by ongoing investments in research and development, strategic partnerships, and mergers and acquisitions. Companies that can effectively tailor their GTM strategies to the evolving market landscape, innovate, and meet shifting consumer demands are likely to achieve sustained success. Companion Animal Diagnostics market report provides a comprehensive analysis of the current market environment and offers valuable insights into the key drivers, challenges, and opportunities that will shape the industry's future over the next decade. This report offers a comprehensive analysis of market dynamics across various segments, regions, and countries, incorporating both qualitative and quantitative data. It covers the period from 2017 to 2035, providing a detailed examination of historical performance, current market conditions, and future projections.

Historical Analysis (2017-2024): The report presents a thorough review of market trends, performance metrics, and growth trajectories for the years 2017 through 2024. This historical perspective is crucial for understanding past market behavior and identifying patterns that influence current and future market dynamics.

Forecast and Projections (2026-2035) : Building on historical data, the report provides forward-looking insights, including market forecasts and growth projections from 2026 to 2035. It details anticipated market trends, emerging opportunities, and potential challenges across different segments, regions, and countries.

Compound Annual Growth Rate (CAGR): The report includes a precise calculation of the compound annual growth rate (CAGR) for the forecast period of 2026 to 2035. This metric will be instrumental in assessing the expected growth trajectory and the overall market potential during the forecast period.

Companion Animal Diagnostics Market

What is the Companion Animal Diagnostics Market

The companion animal diagnostics market refers to the sector focused on providing diagnostic tools, test kits, instruments, and services designed specifically for the health assessment of companion animals such as dogs, cats, horses, and exotic pets. It includes a broad range of diagnostic modalities such as clinical biochemistry, haematology, molecular diagnostics, urinalysis, imaging, and point-of-care testing, which are utilized in veterinary clinics, diagnostic laboratories, and research institutions.

This market is evaluated based on the total revenue generated by manufacturers and service providers offering diagnostic products and related solutions to end users either directly or through distribution channels. It encompasses the sale of diagnostic equipment, consumables, reagents, and associated support services, reflecting the overall economic value derived from companion animal healthcare diagnostics.

• Rising ownership of companion animals, especially in urban regions of North America, Europe, and Asia-Pacific, driving greater awareness and investment in preventive care, diagnostics, and treatments.
• Increased incidence of zoonotic and chronic diseases in pets, such as cancer, diabetes, Lyme disease, and tick-borne infections, prompting adoption of early diagnostic testing.
• Advancements in diagnostic technologies, including molecular diagnostics, immunoassays, imaging, and portable testing devices, enhancing accuracy, speed, and accessibility of veterinary care.
• Growing availability of pet insurance plans in developed markets, reducing out-of-pocket costs and encouraging comprehensive diagnostic evaluations.
• Expansion in the number of veterinary clinics, specialty hospitals, and independent diagnostic laboratories, improving access to veterinary diagnostic services worldwide.

• High cost of advanced diagnostic tools and veterinary care, limiting affordability for middle-income pet owners, particularly in price-sensitive markets.
• Shortage of skilled veterinary professionals and uneven diagnostic infrastructure, leading to underutilization of available technologies in rural and developing regions.
• Regulatory complexity, including compliance with approvals from agencies such as the FDAs Center for Veterinary Medicine and USDA, increasing time-to-market and development costs.
• Market consolidation in veterinary chains creating pricing pressures and limiting opportunities for smaller diagnostic firms and independent practices.
• Access disparities and limited pet insurance coverage for high-end diagnostics, resulting in reduced adoption of comprehensive testing.

North America: Rising pet ownership and humanization of pets drive strong demand for advanced diagnostics. Technological advancements in point-of-care testing, molecular assays, and in-clinic analyzers are transforming veterinary practices. Robust clinic and lab infrastructure supports widespread adoption, with companies like IDEXX launching innovative cancer screening tests for pets.

Europe: Growing pet populations, strong animal welfare policies, and public-private partnerships support diagnostics adoption. Countries like the UK, France, and Germany are expanding molecular and genetic testing services, with increased insurance coverage and preventive medicine fueling demand.

Asia-Pacific: Urbanization, higher incomes, and growing pet health awareness are boosting adoption of PCR testing, imaging, and point-of-care assays in markets such as China, India, Japan, and Australia. Local manufacturers are producing cost-effective solutions for broader market reach.

Latin America: Steady growth in Brazil and Mexico driven by rising pet ownership and disposable incomes. Clinics are equipping themselves with advanced analyzers and rapid tests, while infectious disease screening and collaborations with global firms expand access to modern diagnostics.

Middle East & Africa: Emerging market supported by veterinary infrastructure investments in the UAE, Saudi Arabia, and South Africa. Demand is growing for molecular diagnostics, genetic testing, and mobile platforms. GCC clinics are adopting high-end systems, while other regions benefit from public health surveillance tools.

• United States: ~70% of households (87 million) report pet ownership as of 20222023, driving reliance on early detection and monitoring tools. Strong adoption of point-of-care diagnostics and molecular tests in clinics. Companies like Zoetis and IDEXX expand in-clinic capabilities alongside preventive care programs and telemedicine integration.
• Germany: Preventive pet healthcare awareness is increasing, with dog and cat ownership rising from 40% to 46% between 2017 and 2024. Insurance coverage for diagnostics boosts accessibility, while at-home kits and digital health tracking tools gain popularity.
• Japan: Aging population and cultural fur-baby trend strengthen petowner bonds. Nearly 10 million cats and 9 million dogs outnumber children under 15. Demand for molecular tests, imaging, and AI-enabled diagnostics rises, with digital health apps like CatsMe! supporting proactive monitoring.

The market is highly competitive, with companies focusing on rapid testing kits, real-time diagnostics, and molecular testing platforms. Point-of-care devices, telemedicine integration, and smart diagnostics are key differentiators. Partnerships with clinics, hospitals, and tech providers enhance distribution and data integration capabilities.

• Price competitiveness is vital in cost-sensitive regions, with bundled test panels and multi-analyte systems gaining traction.
• Emerging regional players offer niche solutions for specific breeds or conditions, supported by collaborations with veterinary schools and research institutions.
• Beyond hardware, cloud-based reporting, digital pet health records, and remote interpretation services are becoming part of full-service diagnostic ecosystems.
• Key players: IDEXX Laboratories, Zoetis Inc., Heska Corporation, Thermo Fisher Scientific Inc., Virbac, Neogen Corporation, BioNote Inc., Randox Laboratories, Abaxis (Zoetis), Mars Petcare (Antech Diagnostics), Biomerieux SA, IDEXX BioAnalytics, Scil Animal Care Company GmbH, Fujifilm Corporation, QIAGEN N.V.

• July 2024: Mars acquired Cerba Healthcares stake in Cerba Vet and ANTAGENE, strengthening its Science & Diagnostics division.
• January 2024: Zoetis expanded its Vetscan Imagyst platform with AI-powered urine sediment analysis for in-clinic evaluation.
• May 2024: Zoetis launched the Vetscan OptiCell analyzer, an AI-driven cartridge-based hematology system for advanced in-clinic CBCs.
• February 2025: IDEXX announced strong demand for testing products, including a Cancer Dx screening test for canine lymphoma launching in the U.S. and Canada.

Study Period for the Companion Animal Diagnostics Market:

Companion Animal Diagnostics Market

Report Highlights:

Our team of experienced researchers has meticulously gathered and analyzed data to deliver a thorough examination of market dynamics, competitive landscape, and emerging technologies. With a focus on delivering actionable intelligence, this report aims to empower decision-makers with the information needed to make informed choices and stay ahead of the competition. Whether you are a seasoned industry player or a new entrant, our market research report serves as a strategic tool to navigate the complexities of the market, aiding in successful business planning and growth strategies.

Key Chapters of our Companion Animal Diagnostics Market Report includes:

Market Dynamics, Variables, and Industry Analysis:

This chapter of our Companion Animal Diagnostics market report provides an in-depth examination of the factors shaping the industry landscape. This section typically encompasses several key elements to offer a comprehensive understanding of the industry landscape such as market drivers & restraints analysis, market opportunities & trend analysis, market size & growth analysis, competitive analysis, SWOT analysis, business environment tools such as Porter's five forces & PESTEL analysis, Ansoff Matrix analysis, penetration & growth prospect analysis, regulatory framework & reimbursement scenario analysis, impact of macro & micro economic factors analysis such as Covid-19 impact, GDP growth, market inflation, U.S.- China trade war, Russia-Ukraine war impact, and supply chain analysis.

Segment Analysis & Forecast to 2035:

The segment analysis chapter of Companion Animal Diagnostics market report is a critical section that delves into a detailed examination of the market's various segments. Segmentation involves dividing the market into distinct categories based on certain criteria to better understand and address the diverse needs of consumers. This chapter typically follows the introduction and provides a more granular view of the market, offering valuable insights for businesses and stakeholders. The components of the chapter lude segment definitions to understand the inclusions and exclusions of the study, assumptions, market size estimates and growth trend analysis of each segment, qualitative analysis of the segment, technological advancements, market penetration rate, market adoption rate, market share examination by each segment, segment growth drivers and restraint barriers, consumer behaviour and challenge analysis.

Regional Market Analysis & Forecast to 2035:

The chapter in Companion Animal Diagnostics market research report is a pivotal section that examines and predicts the market dynamics and trends specific to different geographical regions. This chapter is crucial for businesses and stakeholders seeking a comprehensive understanding of how the market behaves across various locations, enabling them to tailor strategies and make informed decisions based on regional variations. The regional analysis chapter of our Companion Animal Diagnostics market report is classified into regions & country-level. The chapter consists of North America (U.S., Canada), Europe (UK, Germany, France, Italy, Spain, Russia, Sweden, Denmark, Norway, Rest of Europe), Asia Pacific (Japan, China, India, Australia, South Korea, Thailand, Rest of Asia Pacific), Latin America (Brazil, Mexico, Argentina, Colombia, Rest of Latin America), Middle East & Africa (South Africa, Saudi Arabia, UAE, Kuwait, Rest of Middle East & Africa).

Companion Animal Diagnostics Market

Competitive Analysis & Company Profiles:

This section of a Companion Animal Diagnostics market report is a crucial segment that provides a comprehensive overview of the competitive landscape within the market. This section is vital for businesses, investors, and stakeholders seeking insights into key players, their market positioning, strengths, weaknesses, strategies, and potential impacts on the overall market dynamics. The chapter includes research methodology used to analyse the market competition, list of key players operating in the market, detailed company profile section which includes company overview, business verticals, financial performance, product/services benchmarking, geographical presence, and strategic initiatives.

• IDEXX Laboratories
• Zoetis Inc.
• Heska Corporation
• Thermo Fisher Scientific Inc.
• Virbac
• Neogen Corporation
• BioNote Inc.
• Randox Laboratories
• Abaxis (a Zoetis company)
• Mars Petcare (via Antech Diagnostics)
• Biomerieux SA
• IDEXX BioAnalytics
• Scil Animal Care Company GmbH
• Fujifilm Corporation
• QIAGEN N.V.

Companion Animal Diagnostics Market

Report Scope:

Based on Technlogyy, the Companion Animal Diagnostics market is segmented into:

• Flow Cytometry
• Polymerase Chain Reaction (PCR)
• Next Generation Sequencing (NGS)
• Others

Based on Cancer Type, the Companion Animal Diagnostics market is segmented into:

• Hematological Malignancy
• Leukemia
• Lymphoma
• Solid Tumors

Based on Target Biomarker, the Companion Animal Diagnostics market is segmented into:

• DNA-based
• RNA-based
• Cell Surface Markers
• Gene Rearrangements
• Fusion Genes
• Others

Based on End Use, the Companion Animal Diagnostics market is segmented into:

• Academic and Research Institutes
• Diagnostics Laboratories
• Hospitals and Specialty Clinics
• Contract Research Organizations (CROs)
• Others

Key Reasons to Acquire the Companion Animal Diagnostics Market Research Report:

• This report offers a comprehensive analysis of the Companion Animal Diagnostics market from 2017 to 2035, including market segments, current trends, estimations, and dynamics
• It also provides information on key drivers, restraints, and opportunities
• Porter's five forces analysis is used to assess the potency of buyers and suppliers, helping stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network
• The report includes an in-depth analysis of the Companion Animal Diagnostics market segmentation to identify prevailing market opportunities
• Major countries in each region are mapped according to their revenue contribution to the global market
• Market player positioning is also analyzed to facilitate benchmarking and provide a clear understanding of the present position of the market players
• The report includes an analysis of the regional and global Companion Animal Diagnostics market trends, key players, market segments, application areas, and market growth strategies

Companion Animal Diagnostics Market

Available Customizations:

With the given market data, Quintile Reports offers customizations according to the company's specific needs. The following customization options are available for the report:

• You may ask for a global, regional, or country-specific report.
• You may ask if there are any particular types, applications, or products on which you would like to focus.
• You may ask for specific competitors/players to be profiled.

Companion Animal Diagnostics Market Report

Statistics for the 2025 Companion Animal Diagnostics market share, size, and revenue growth rate were created by Quintile Report™. Companion Animal Diagnostics analysis includes a market forecast outlook for 2035 and a historical overview. Get a free PDF sample of this market analysis, please get in touch with our principal analyst at sales@quintilereports.com